Nearly all Americans are now aware of GLP-1 medications, with many expressing interest as adoption continues to rise. A new U.S. study, "Beyond Weight Loss" from Reach3 Insights finds that 92% of ...
KELOWNA, BC / ACCESS Newswire / April 1, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the ...
You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...
VANCOUVER, BC / ACCESS Newswire / March 30, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") ...
Why more doctors are prescribing GLP-1s for small amounts of weight loss GLP-1 medications like Ozempic, Wegovy, and Zepbound have quickly become tools for helping people with obesity and diabetes ...
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
Please provide your email address to receive an email when new articles are posted on . A narrative review found that GLP-1 receptor agonists may significantly lower risks for ocular hypertension and ...
WeightWatchers Med+ is now offering an oral GLP-1 medication for weight loss. The new daily pill is the first FDA-approved oral GLP-1 for weight management. Clinical trials showed weight loss results ...
KELOWNA, BC / ACCESS Newswire / April 1, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results